West Pharmaceutical Services, Inc. (WST)

341.70 0.76%
02:29 pm EDT; Powered by IEX
Pros
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages
Company’s profitability is declining
Forward P/E ratio high relative to industry peers
Forward PEG ratio high relative to industry peers

Pros

  1. WST average analyst rating is Buy. See WST analyst rating chart.
  2. WST average analyst price target ($386.50) is above its current price ($341.89). See WST price target chart.

Cons

  1. WST quarterly revenue growth was 7.40%, lower than the industry and sector average revenue growth (10.76% and 7.51%, respectively). See WST revenue growth chart.
  2. WST profitability is declining. The YoY profit margin change was -0.09 percentage points. See WST profitability chart.
  3. WST forward P/E ratio is 37.96, which is high compared to its industry peers’ P/E ratios. See WST forward P/E ratio chart.
  4. WST PEG ratio (P/E adjusted for growth) is 3.06, which is high compared to its industry peers’ PEG ratios. See WST PEG chart.